Walser Wealth Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$603K Buy
2,305
+272
+13% +$69.7K 0.24% 101
2026
Q2
$512K Buy
2,033
+487
+32% +$105K 0.21% 112
2026
Q1
$336K Buy
+1,546
New +$343K 0.15% 115

Other funds holding ABBV

Walser Wealth Management's ABBV Position: Q3 2026 in Review

Walser Wealth Management increased its AbbVie (ABBV) stake by 13% in Q3 2026, buying an estimated $69.7K and bringing the position to 2,305 shares worth $603K. The position accounts for 0.24% of the portfolio, ranked #101.

Walser Wealth Management first reported a position in ABBV in Q1 2026 and has held it in 3 quarters since. 4,285 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Walser Wealth Management held 2,305 shares of AbbVie worth $603K as of Q3 2026.
  • Walser Wealth Management bought 272 AbbVie shares in Q3 2026, an estimated $69.7K.
  • AbbVie made up 0.24% of Walser Wealth Management's portfolio in Q3 2026, its #101 holding.
  • Walser Wealth Management first reported a position in AbbVie in Q1 2026 and has held it in 3 quarters since.
  • 4,285 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Walser Wealth Management's 13F filing for Q3 2026, filed 15 Oct 2026.